Bavelloni, A., M. Piazzi, G. Ramazzotti, R. Fiume, W. Blalock, and I. Faenza. “PI3Kα-Selective Inhibitor Alpelisib (BYL719), May Be Effective As Anticancer Agents in Rhabdomyosarcoma”. Italian Journal of Anatomy and Embryology, vol. 122, no. 1, Oct. 2017, p. 21, https://oajournals.fupress.net/index.php/ijae/article/view/1730.